side effects for tirzepatide Effects: What to Expect (and When to Worry) 20 Possible Tirzepatide Side Effects

Epidemiology Demographics 30 to 55 years for solitary neurofibromas 20 to 40 years for neurofibromatosis type 1 (NF-1) Etiology Genetics most cases associated with NF-1 4% incidence in these patients Presentation Presentation soft-tissue mass most arise from large nerves (sciatic, brachial plexus) motor and sensory deficit of the affected nerve Imaging Radiograph usually normal or non-specific soft-tissue mass MRI low-intensity on T1-weighted images high intensity on T2-weighted images serial MRI may show enlargement of previous benign nerve sheath lesion suggesting malignant transformation Bone scan mildly positive Studies Histology classic characteristics are spindle cells with wavy nuclei resembling fibrosarcoma Immunohistochemistry positive S100 stain keratin staining is negative Treatment Operative wide surgical resection + radiation indications technique radiation chemotherapy not useful Prognosis Survival for solitary lesion is 75% (5-year survival) Survival associated with NF-1 is 30% (5-year survival) Create a free account or log in to see the cards.

And were talking about several observational and randomized controlled studies here

Standard IGF-1 remains important for in vivo studies where IGFBP interactions are part of the biological system under investigation

Empagliflozin inhibits neuronal ferroptosis induced by oxygen-glucose Deprivation/Reo-xygenation by activating the Nrf2/HO-1 pathway

Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein